ImmusanT, Inc. — Form D
ImmusanT, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-14. The offering totals $39.9M, of which $19.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-14
- Form: D
- Accession: 0001538991-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $39.9M
- Amount sold: $19.9M
- Remaining: $20.0M
- Investors: 3
- Date of first sale: 2017-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298664
Issuer
- Name: ImmusanT, Inc.
- CIK: 0001538991
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: One Kendall Square, CAMBRIDGE, MA, 02139
- Phone: 617-401-2154
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Thomas Daniel | Director | San Francisco, CA |
| Kevin Ferro | Director | Cambridge, MA |
| Steven Gillis | Director | South San Francisco, CA |
| Ceclia Gonzalo | Director | Cambridge, MA |
| Thomas Koestler | Director | Cambridge, MA |
| Leslie Williams | Director | Cambridge, MA |
| Leslie Williams | Executive Officer | Cambridge, MA |
| Craig Estwick | Director | CAMBRIDGE, MA |
| Justin Sun | Director | CAMBRIDGE, MA |
| Sundar Kodiyalam | Director | CAMBRIDGE, MA |
Other filings by this issuer (1)
More